Centiva Capital’s Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share PHYT.WS Stock Holding History

Centiva Capital’s Portfolio PHYT.WS Stock Details PHYT.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,650	Closed	-$320	–	2600
2024 Q1	$320	Hold	10,650	–	–	﹤0.01%	1709
2023 Q4	$852	Sell	10,650 -70,550	-87%	-$5.3K	﹤0.01%	1718
2023 Q3	$5.68K	Hold	81,200	–	–	﹤0.01%	1661
2023 Q2	$8.12K	Sell	81,200 -18,800	-19%	-$1.75K	﹤0.01%	1556
2023 Q1	$12K	Hold	100,000	–	–	﹤0.01%	1441
2022 Q4	$8K	Hold	100,000	–	–	﹤0.01%	1298
2022 Q3	$16K	Hold	100,000	–	–	﹤0.01%	1390
2022 Q2	$30K	Hold	100,000	–	–	﹤0.01%	1489
2022 Q1	$45K	Buy	+100,000	New	+$46.3K	﹤0.01%	1432

Other funds holding PHYT.WS

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Centiva Capital's PHYT.WS Position: Q2 2024 in Review

Centiva Capital sold out of Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (PHYT.WS) in Q2 2024, closing a stake of 10,650 shares — an estimated $320 sold.

Centiva Capital first reported a position in PHYT.WS in Q1 2022 and held it in 9 quarters. The position peaked at $45K in Q1 2022. 31 funds tracked by Wall St. Rank hold PHYT.WS as of Q2 2024.

Centiva Capital reported no remaining Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q2 2024 after selling out during the quarter.
Centiva Capital sold 10,650 Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q2 2024, an estimated $320.
Centiva Capital first reported a position in Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q1 2022 and held it in 9 quarters.
Centiva Capital's Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $45K in Q1 2022.
31 funds tracked by Wall St. Rank held Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q2 2024.

Based on Centiva Capital's 13F filing for Q2 2024, filed 14 Aug 2024.